Australian Drug Maker Has Low Profile but Powerful Backers in Washington

Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.
By KATIE THOMAS from NYT Health http://ift.tt/2jhORMb
via IFTTT
United States Politics and Government, Drugs (Pharmaceuticals)
Source The New York Times
Làm đẹp Blog 247